Antithrombotic treatment in atrial fibrillation. Response to: Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC: the risks of warfarin use in the elderly. Expert Opin. Drug Saf. (2006) 5(3):417-431

Expert Opin Drug Saf. 2006 Jul;5(4):485-6. doi: 10.1517/14740338.5.4.485.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Acenocoumarol / adverse effects
  • Aged
  • Anticoagulants / adverse effects*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Salicylates / therapeutic use*
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control*
  • Treatment Outcome
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Salicylates
  • triflusal
  • Warfarin
  • Acenocoumarol